Elevance Health Inc. (NYSE:ELV) entered into an agreement to acquire BioPlus Specialty Pharmacy Services, LLC from CarepathRx on November 9, 2022. The transaction is subject to the expiration or termination of applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and other customary closing conditions and is expected to close in the first half of 2023. Elevance Health, Inc. newly issued three senior unsecured notes part of the proceeds may be used toward closing the earlier announced acquisition - BioPlus.

The transaction is expected to close later in 2023. BioPlus is not expected to have a material impact on adjusted earnings per share in 2023. Centerview Partners acted as lead financial advisor and Cantor Fitzgerald is also acting as financial advisor to CarepathRx and Nautic.

Michael J. Sartor, P.C.,Armand A. Della Monica, P.C. ,William Nale Lay of Kirkland & Ellis, LLP acted as legal advisor to CarepathRx and Nautic.